References
- 1. Available at: http://papardeszieds.lv/en/index.php?option=com_content&view=article&id=134:sexual-and-reproductive-health-research-inlatvia-&catid=11:projects&Itemid=40. Accessed September 2012
- 2. Bender NM, Segall-Gutierrez P, Najera SO, et al. Efeects of progestin-only long-acting contraception on metabolic markers in obese women// Contraception, Forthcoming 2013
- 3. Eurostat Newsrelease 172/2011-24 November 2011, European Health Interview Survey, Between 8% and 25% of adults are obese across Member States. Available at: http://epp.eurostat.ec.europa.eu/statistics_explained/index.php/Overweight_and_obesity_-_BMI_statistics and http://epp.eurostat.ec.europa.eu/cache/ITY_PUBLIC/3-24112011-BP/EN/3-24112011-BP-EN.PDF1
- 4. Kaykicioglu F, Gunes M, Ozdegirmenci O, Haberal A. Effects of the levonorgestrel-releasing hormone system on glucose and lipid metabolism: a 1-year follow-up study// Contraception, 2006; 73:528-31
- 5. Morin-Papunen L, Martikainen H, McCarthy MI, et al. Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population// Am J Ostet Gynecol, 2008; 199:529.1- 10
- 6. Mosca L, Benjamin E J, Berra K et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women- 2011 update: a guideline from the American Heart Association// Circulation 123(11), 1243-1262(2011)
- 7. National health Service. Available at: http://vec.gov.lv/uploads/files/4d00e0402bec2.pdf
- 8. Varma R, Sinha D, Gupta J. Non- contraceptive uses of levonorgestrel-releasing hormone system(LNG-IUS)- a systematic enquiry and overview// Eur J Obstet Gynecol Reprod Biol, 2006; 125:9-28
- 9. Woo NY, Liang S, Singh K. Effects of Mirena (levanoregestrel- releasing intrauterine system) and Ortho Gyanae T380 intrauterine copper device on lipid metabolism- a randomized comparative study// Contraception, 2009;79:24-8